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observed among non-obese Asians (BMI <25 kg/m 2 ). 5,14, 15 Therefore, measuring BF% would be useful to detect individuals with CVD risks, even in the normal range of BMI or WC. It is crucial to detect the presence of early stage CVD risk accumulation in the primary prevention. Bioelectrical impedance analysis (BIA) is widely accepted as a safe, rapid, low cost, and reliable technique to estimate BF%. [16] [17] [18] BF% determined by BIA is widely used at home and in medical check-ups for screening measurement of an individual's body composition because of its simplicity. However, the clinical significance of measuring BF% by BIA has not been well studied in detail. The information derived from the body fat scale would add value to evaluate individual health condition.
Smoking is still prevalent in Japan as well as Asian countries, and is one of the chief determinants of adult mortality from CVD and other non-communicable diseases. 19-21 Current smokers show a high prevalence of CVD risk factors as well as high incidence of CVD even though they have lower body weight than never or ex-smokers. [22] [23] [24] [25] Smoking is associated with visceral fat accumulation, 26 insulin resistance, 27 and metabolic syndrome. 28, 29 Considering these results, we need to examine the cut-off points of anthropometric markers in individuals stratified by smoking status.
Thus, we investigated the associations of BF% with CVD risk factors, and evaluated the usefulness of BF% in comparison with BMI and WC to detect participants with hypertension, dyslipidemia, and DM in a Japanese male population. Additionally, we stratified subjects according to current smoking status, and compared the associations of the anthropometric markers and CVD risk factors.
Methods

Study Population
We performed a cross-sectional study on a cohort of 14,087 middle-aged Japanese men who underwent annual medical check-ups at their workplaces during April 2008 to December 2008. In this analysis, we excluded individuals with a history of CVD, cancer, or those who had been on medication for hypertension, DM, or dyslipidemia whose anthropometric measures might have been changed as a result of these underlying diseases and treatments, leaving 10,774 men eligible for the present analysis.
The study protocol was approved by the Ethics Review Committee of Nagoya University Graduate School of Medicine, Nagoya, Japan.
Baseline Examination and Analysis of Blood Samples
Anthropometric measurements were taken in the standing position while the participants wore light clothing and no shoes. Height was measured to the nearest 0.1 cm using a portable stadiometer and weight was measured to the nearest 0.1 kg using an electronic scale that was calibrated prior to each measurement. BMI was calculated as weight in kilograms divided by the square of the height in meters. WC was measured to the nearest 0.1 cm at the umbilical level. BF% was estimated by BIA using the standard tetrapolar technique according to the manufacturer's instructions for distal electrode placement on both feet (a stand-on mode, TBF-210, TANITA, Tokyo, Japan).
Trained nurses obtained information on smoking and past medical history in face-to-face 15-30 min interviews. Subjects responded to an item which classified them as current or nonsmokers. Current smokers were defined as those who had been smoking for at least a year.
We used the blood sample data from physical check-ups of the participants. Blood samples were drawn from the individuals after overnight or 8 h fasting for determination of the serum lipids and plasma glucose.
Definition of CVD Risk Factor Clustering
We used the criteria for CVD risk factors proposed by the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (NCEP-ATPIII). 30 Patients with systolic blood pressure ≥140 mmHg and/or diastolic BP ≥90 mmHg were defined as having hypertension. Abnormal levels of serum lipids were defined as follows: LDL-C ≥3.63 mmol/L, highdensity lipoprotein cholesterol <1.04 mmol/L, and triglycerides ≥1.70 mmol/L. Dyslipidemia was defined as abnormal levels of at least one of the serum lipids. Patients with fasting plasma glucose ≥7.0 mmol/L were defined as having DM.
Statistical Analysis
Continuous variables are expressed as mean ± standard deviation (SD). Lipids and fasting plasma glucose were naturally logarithmically transformed to approximately normalize the distribution and used in the analysis, transformed back for data presentation, and are shown as geometric means and the 95% confidence intervals (95% CI). Categorical variables were expressed as percentages and were compared with a chi-square test. Receiver-operating characteristics (ROC) curves were plotted using measures of sensitivity and 1-specificity based on the cutoff values for various anthropometric markers. The area under To obtain the optimal cut-off point for anthropometric markers in detecting individuals with CVD risk factors, we chose the point on the ROC curves that showed the largest Youden index (sensitivity+ specificity-1). 31 We considered subjects whose anthropometric markers were higher than cut-off points as high risk group. Odds ratios (OR) were calculated using multiple logistic regression analysis with adjustments for age and current smoking status. The effects of reclassification using anthropometric markers were assessed using recently published methods that estimated the net reclassification improvement (NRI). 32 Improvement in reclassification was estimated by taking the sum of differences in proportions of participants reclassified high-risk categories minus the proportion reclassified low-risk categories for people who had CVD risks and the proportion of subjects moving lowrisk categories minus the proportion moving high-risk categories for people who did not have CVD risks. Using this method, the overall sum is defined as the NRI. A P-value of less than 0.05 was considered statistically significant. All statistical analyses were conducted using SPSS statistical package for Windows version 19.0 J (SPSS Inc, Chicago, IL, USA).
Results
Baseline Characteristics
The baseline characteristics of the study subjects and the prevalence of CVD risk factors are shown in Figure 1 shows the adjusted odds ratios for detecting subjects with CVD risk factors according to anthropometric markers, categorized by quintiles. All anthropometric markers showed significantly positive correlation with the prevalence of CVD risk factor(s). Adjusted OR of 1 or more and 2 or more CVD risk factors increased steeply with increasing BF% quintiles and to a lesser extent with increasing BMI and WC quintiles. However, WC showed higher OR for having 3 risk factors than BMI and BF%. Table 2 shows the results of ROC curve analyses. AUC for BF% was higher for having 1 or more CVD risk factors (AUC=0.689) compared with those for BMI or WC. The cut-off points of BMI, WC, and BF% detecting subjects with 1 or more, 2 or more, and 3 CVD risk factors ranged from 22.7 to 24.7 kg/m 2 , from 81.4 to 88.0 cm and from 20.3 to 23.0%, respectively. When detecting participants with 1 or more and 2 or more CVD risk factors, sensitivity of BF% cut-off points showed higher values than those of BMI and WC, whereas specificity of BMI showed higher values than those of BF% and WC. According to the analyses of components of CVD risk factors, AUC for BF% was the highest for dyslipidemia (AUC=0.682) among the 3 anthropometric markers. Dyslipidemia emerged at lower cut-off points of all these anthropometric markers, whereas DM emerged at higher cut-off points. Shown in Table 3 are the OR of each anthropometric marker categorized by each cut-off value for the presence of CVD risk factors. All anthropometric markers were significantly associated with CVD risk factors even after adjustment for age and current smoking status. Then we adjusted for anthropometric markers simultaneously. BF% cut-off points showed higher OR for detecting individuals with CVD risk factors except for hypertension than BMI and WC cut-off points.
Association of Quintiles of Anthropometric Markers With CVD Risk Factors
Cut-Off Points of Anthropometric Markers and CVD Risk Factors
We then assessed the NRI of WC and BF% compared with BMI by using each cut-off point (Figure 2) . BF% cut-off point detecting subjects with 1 or more CVD risk factors classified 3.43% more subjects into the correct categories than BMI cut-off points (P<0.001). BF% cut-off point detecting subjects with dyslipidemia classified 4.06% more subjects into the correct categories than the BMI cut-off points (P<0.001).
As for detecting participants with 2 or more CVD risk factors, BMI cut-off point classified 3.23% more subjects into the correct categories than the WC cut-off point. We additionally calculated cut-off points in the sensitivity range of 80% or more ( Table 4) . Under this condition, BF% cut-off points classified 3.45% and 5.33% more participants into the correct categories than BMI cut-off points did when detecting subjects with 1 or more, and 2 or more CVD risk factors, respectively (Figure 3) .
Cut-Off Points of Anthropometric Markers Stratified by Smoking Status
The results of ROC analyses, OR, and NRI stratified by current smoking status are shown in Table 5 . The cut-off points of anthropometric markers for current smokers were lower than those for non-smokers. The cut-off points of BMI, WC, and BF% for detecting subjects with 1 or more, 2 or more, and 3 CVD risk factors in current smokers were 23.7, 24.7, and 24.9 kg/m 2 , 83.1, 87.5, and 87.8 cm, and 20.4, 22.0, and 23.7%, while those in non-smokers were 22.9, 23.9, and 23.3 kg/m 2 , 81.4, 84.2, and 83.9 cm, and 20.3, 21.2, and 22.3%, respectively. As the number of CVD risk increased, the differences between the cut-off points for smokers and those for non-smokers tended to increase. NRI analysis demonstrated that BF% cut-off points for detecting subjects with 1 or more CVD risk factors classified more subjects into the correct categories than BMI cut-off points even in both current smokers and non-smokers.
Discussion
Our results clarified that in the middle-aged Japanese male workers, BF% measured by BIA could detect subjects who have 1 or 2 CVD risk factors more accurately than BMI. We could not find out the superiority of WC over BMI among subjects having 1 or 2 CVD risk factors. Current smokers showed smaller cut-off points for detecting subjects with CVD risk factors than non-smokers.
Obesity is a medical condition in which excess body fat has accumulated to the extent that it causes adverse effects on ment of anthropometric markers to evaluate more precise CVD risk in each population group is also important. Several epidemiologic studies have shown that Asians have higher amounts of body fat at lower BMI and WC than Western populations. 11, 13 The Regional Office for Western Pacific Region of WHO proposed a separate classification of obesity for Asia that adult overweight be defined as a BMI ≥23.0 kg/m 2 , and that obesity be defined as a BMI ≥25.0 kg/m 2 (WPRO criteria). 15 In the present study, the cut-off points of BMI for detecting individuals with 1 or more and 2 or more CVD risk factors were in the overweight range of the WPRO criteria. Overweight subjects proposed by the WPRO criteria have higher risks for metabolic disorders in a Japanese population, 5 so, cut-off points of BMI described in this study would be reasonable.
Recently, WC has been proposed as more sensitive measurements of visceral obesity and more indicative of cardiovascular risk. WC criterion for abdominal obesity suggested by NCEP-ATPIII and the International Diabetes Federation (IDF) is 90 cm for Asian male 36 and that suggested by Japan Society for the Study of Obesity (JASSO) is 85 cm. 6 Some studies in Asia also showed that the optimal WC cut-off points for men are smaller than IDF criterion. 37, 38 In line with those data, the cut-off points of WC for detecting subjects with 1 or more and 2 or more CVD risk factors were smaller in this study than those of NCEP-ATPIII, IDF, and JASSO criteria.
WC showed stronger association with the presence of the 3 CVD risk factors. However, the ability of BF% to detect patients with CVD risk factors was superior to BMI, and especially useful when detecting individuals with 1 or more CVD risk factors. Given that anthropometric markers are used for the first screening of subjects as methods of detecting the individuals who have CVD risk factors, the cut-off point should have a high sensitivity of at least 80% despite the decreasing of specificity. In this sense, BF% was superior to BMI when detecting subjects with 1 or more, and 2 or more CVD risk factors, whereas there was no significant difference between WC and BMI. Additionally, the population attributable risk is larger in non-obese individuals with 1 or 2 risk factors than those with metabolic syndrome in Japan. 39, 40 Therefore, assessing the presence of not only metabolic syndrome but classical risk factors such as hypertension, DM, and dyslipidemia is important to prevent the incidence of CVD. [39] [40] [41] [42] It is crucial to predict the presence of early stage CVD risk accumulation in the primary prevention.
BF% showed stronger association with the prevalence of dyslipidemia than BMI and WC. Dyslipidemia has been reported to precede the appearances of blood pressure elevation, fasting glucose elevation, and WC enlargement, 43 and BF% has been suggested to be superior to BMI for detecting subjects with dyslipidemia in a previous study. 44 In the presence of a positive net energy balance, there is increased accumulation of triglycerides in both adipose tissues and non-adipose tissues, such as muscle and liver. 45 Intramyocellular lipid, a triglycerides compartment in myocyte, is positively correlated with insulin resistance, 45, 46 and that in tibialis anterior muscle was reported to be positively correlated with BF%. 47 Additionally BF% by BIA is a simple way to measure by oneself. Therefore, BF% can be a good method to detect individuals with early stage metabolic disorder.
There is increasing evidence that smoking affects body fat distribution and is associated with central obesity and insulin resistance. 48, 49 Mean BMI of smokers is lower than that of non-smokers, which is suggested to be caused by increased energy expenditure resulting from the sympathetic nervous system activation, 23 and/or lower calorie intake caused by appetite-suppressing action of nicotine. 50 However, a previous study reported that smokers show higher prevalence of hypertension, hyperglycemia, and dyslipidemia than never smokers among the non-obese subjects, although WC were not significantly different. 25 In our study, the cut-off points of anthropometric markers for current smokers were lower than those for non-smokers. In current smokers, the metabolic disorders would progress before body shape starts to change. Therefore, it is important to obtain information of smoking status when we measure the anthropometric markers.
There are some limitations that should be taken into consideration. First, BF% by BIA is affected by individual and environmental factors such as age, sex, time of measurement carried out, consumption of food or beverage, sweating, and physical activity. The BIA prediction equations vary depending on populations and equipments used. However, all participants in the present study were Japanese males and we used the same type of body composition analyzer validated for Japanese. Moreover, we measured BF% under the controlled conditions: in the fasting state and before working in the morning. Second, the present findings might not apply directly to other populations. Third, the number of subjects with 3 CVD risk factors was small. Further investigation in higher risk group is needed to clarify more reliable cut-off points of anthropometric markers for detecting the presence of 3 risk factors.
In conclusion, anthropometric markers are useful in evaluating CVD risk factors in that the abnormal values are well corresponded with the presence of dyslipidemia, hypertension, and/or DM. In particular, BF% is a useful marker to identify subjects of early stage of developing CVD who have 1 or 2 CVD risk factors. Furthermore, our study suggests that the cut-off values of the anthropometric markers for detecting individuals with CVD risk factors should be lower in current smokers than in non-smokers. To confirm generalizability of the present findings, it is necessary to investigate the significance of using BF% by BIA to predict the prevalence of hypertension, DM, and dyslipidemia in other cohorts.
